Ever Source Wealth Advisors, LLC Nautilus Biotechnology, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 378 shares of NAUT stock, worth $461. This represents 0.0% of its overall portfolio holdings.
Number of Shares
378
Previous 145
160.69%
Holding current value
$461
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NAUT
# of Institutions
74Shares Held
63.4MCall Options Held
158KPut Options Held
0-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA16.3MShares$19.9 Million24.08% of portfolio
-
Perceptive Advisors LLC New York, NY12.6MShares$15.4 Million0.4% of portfolio
-
Cercano Management LLC Bellevue, WA7.17MShares$8.75 Million0.16% of portfolio
-
Madrona Venture Group, LLC6.02MShares$7.35 Million34.58% of portfolio
-
Black Rock Inc. New York, NY3.83MShares$4.67 Million0.0% of portfolio
About Nautilus Biotechnology, Inc.
- Ticker NAUT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,663,000
- Market Cap $152M
- Description
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...